NCT00520091
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
- Locations
-
Not specified
Clinical trial condition
Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
404 public trials
129 recruiting studies
Esophageal Squamous Cell Carcinoma trial results
Completed
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
NCT00900094
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +59 more
- Locations
-
Not specified
NCT00002506
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +46 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Bloomington Hospital Bloomington, Indiana, United States
- St. Vincent Hospital and Health Care Center Indianapolis, Indiana, United States
- Bergan Mercy Medical Center Omaha, Nebraska, United States
NCT00066716
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
- Locations
-
- New York Weill Cornell Cancer Center at Cornell University New York, United States
Active, Not Recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
NCT06781983
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
- Locations
-
- Massachusetts General Hospital - Boston Boston, Massachusetts, United States
- John Theurer Cancer Center Hackensack, New Jersey, United States
- Mount Sinai Tisch Cancer Center New York, United States
- NEXT Oncology - Dallas Dallas, Texas, United States
Active, Not Recruiting
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
NCT04543617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Florida Cancer Specialists - Fort Myers (Broadway) Fort Myers, Florida, United States
- Cancer Center of Kansas Wichita, Kansas, United States
- Great Lakes Cancer Center Williamsville, New York, United States
- Instituto de Investigaciones Metabolicas (Idim) Buenos Aires, Argentina
Active, Not Recruiting
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
NCT06304974
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC
NCT07711470
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China
Active, Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
- Locations
-
- Institut de cancérologie de l'Ouest Angers, France
- Clinique Sainte Catherine Avignon, France
- Centre Hospitalier de la Côte Basque Bayonne, France
- CHU Bordeaux - Hôpial Saint André Bordeaux, France
Active, Not Recruiting
O-GlcNAcylation Induced HMGB1 Signalling
NCT07702253
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong Hong Kong